Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man
- 31 December 1985
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 29 (2) , 157-204
- https://doi.org/10.1016/0163-7258(85)90028-2
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- Drugs and drug metabolites as environmental contaminants: Chlorophenoxyisobutyrate and salicylic acid in sewage water effluentPublished by Elsevier ,2002
- Preparation of carbon‐14 labelled ethyl 2‐(P‐chlorophenoxy)‐2‐methyl propionate (CLofibrate; atromid‐S); clofibric acid and clofibric amideJournal of Labelled Compounds and Radiopharmaceuticals, 1983
- Uricosuric Effect of Fenofibrate in Healthy VolunteersThe Journal of Clinical Pharmacology, 1980
- Absorption of nicotinic acid and nicotinamide from rat small intestine in vitroBiochimica et Biophysica Acta (BBA) - Biomembranes, 1980
- The Effect of Colestipol Hydrochloride on the Bioavailability and Pharmacokinetics of ClofibrateThe Journal of Clinical Pharmacology, 1979
- Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarinJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Conversion ofβ-sitosterol to steroid hormones by rat testes in vitroCellular and Molecular Life Sciences, 1975
- In Vitro Binding of Drugs to Colestipol HydrochlorideJournal of Pharmaceutical Sciences, 1974
- Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandoz 42–348) on steroid and drug metabolism by rat liver microsomesLife Sciences, 1970
- Initial distribution in mice of 3H-labeled nicotinic acid studied with autoradiographyLife Sciences, 1964